139 related articles for article (PubMed ID: 8195818)
21. Construction of an infectious DNA clone of the full-length human spumaretrovirus genome and mutagenesis of the bel 1 gene.
Löchelt M; Zentgraf H; Flügel RM
Virology; 1991 Sep; 184(1):43-54. PubMed ID: 1651600
[TBL] [Abstract][Full Text] [Related]
22. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
[TBL] [Abstract][Full Text] [Related]
23. Absence of serological evidence for foamy virus infection in patients with amyotrophic lateral sclerosis.
Rösener M; Hahn H; Kranz M; Heeney J; Rethwilm A
J Med Virol; 1996 Mar; 48(3):222-6. PubMed ID: 8801281
[TBL] [Abstract][Full Text] [Related]
24. Measles virus antibodies in serum and cerebrospinal fluid in patients with multiple sclerosis and other neurological disorders, with special reference to measles antibody synthesis within the central nervous system.
Vandvik B; Degré M
J Neurol Sci; 1975 Feb; 24(2):201-19. PubMed ID: 1113135
[TBL] [Abstract][Full Text] [Related]
25. Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker.
Krametter D; Niederwieser G; Berghold A; Birnbaum G; Strasser-Fuchs S; Hartung HP; Archelos JJ
Mult Scler; 2001 Feb; 7(1):13-8. PubMed ID: 11321187
[TBL] [Abstract][Full Text] [Related]
26. Absence of antibodies to HTLV-I and HIV in serum and cerebrospinal fluid of Italian patients with multiple sclerosis.
Merelli E; Sola P; Montagnani G; Baldini E
J Neurol Sci; 1988 Apr; 84(2-3):337-9. PubMed ID: 2837543
[TBL] [Abstract][Full Text] [Related]
27. Measles virus-specific immunoglobulin D antibody in cerebrospinal fluid and serum from patients with subacute sclerosing panencephalitis and multiple sclerosis.
Patrick BA; Mehta PD; Sobczyk W; Kulczycki J; Woyciechowska-Camenga J; Camenga D; Thormar H
J Neuroimmunol; 1990 Jan; 26(1):69-74. PubMed ID: 2294143
[TBL] [Abstract][Full Text] [Related]
28. Correlation between DJ-1 levels in the cerebrospinal fluid and the progression of disabilities in multiple sclerosis patients.
Hirotani M; Maita C; Niino M; Iguchi-Ariga S; Hamada S; Ariga H; Sasaki H
Mult Scler; 2008 Sep; 14(8):1056-60. PubMed ID: 18632777
[TBL] [Abstract][Full Text] [Related]
29. Incidence of antibody to HTLV-I is not increased in Japanese MS patients.
Kuroda Y; Shibasaki H; Sato H; Okochi K
Neurology; 1987 Jan; 37(1):156-8. PubMed ID: 3025773
[TBL] [Abstract][Full Text] [Related]
30. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls.
Xiao BG; Linington C; Link H
J Neuroimmunol; 1991 Feb; 31(2):91-6. PubMed ID: 1991822
[TBL] [Abstract][Full Text] [Related]
31. Retroviral synthetic peptide serum antibodies in human sporadic amyotrophic lateral sclerosis.
Westarp ME; Föring B; Rasmussen H; Schraff S; Mertens T; Kornhuber HH
Peptides; 1994; 15(2):207-14. PubMed ID: 8008625
[TBL] [Abstract][Full Text] [Related]
32. Humoral immunity response to human endogenous retroviruses K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases.
Arru G; Mameli G; Deiana GA; Rassu AL; Piredda R; Sechi E; Caggiu E; Bo M; Nako E; Urso D; Mariotto S; Ferrari S; Zanusso G; Monaco S; Sechi G; Sechi LA
Eur J Neurol; 2018 Aug; 25(8):1076-e84. PubMed ID: 29603839
[TBL] [Abstract][Full Text] [Related]
33. Antibodies to simian virus 5 in patients with multiple sclerosis and other neurological disorders.
Brankin B; Wisdom GB; Allen IV; Hawkins SA; Cosby SL
J Neurol Sci; 1989 Feb; 89(2-3):181-7. PubMed ID: 2538574
[TBL] [Abstract][Full Text] [Related]
34. Antibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseases.
Rawes JA; Calabrese VP; Khan OA; DeVries GH
Mult Scler; 1997 Dec; 3(6):363-9. PubMed ID: 9493635
[TBL] [Abstract][Full Text] [Related]
35. Antibodies against Gag are diagnostic markers for feline foamy virus infections while Env and Bet reactivity is undetectable in a substantial fraction of infected cats.
Romen F; Pawlita M; Sehr P; Bachmann S; Schröder J; Lutz H; Löchelt M
Virology; 2006 Feb; 345(2):502-8. PubMed ID: 16297422
[TBL] [Abstract][Full Text] [Related]
36. Specificity of recombinant antibodies generated from multiple sclerosis cerebrospinal fluid probed with a random peptide library.
Yu X; Gilden DH; Ritchie AM; Burgoon MP; Keays KM; Owens GP
J Neuroimmunol; 2006 Mar; 172(1-2):121-31. PubMed ID: 16371235
[TBL] [Abstract][Full Text] [Related]
37. Terminal component of complement C9 in CSF and plasma of patients with MS and aseptic meningitis.
Halawa I; Lolli F; Link H
Acta Neurol Scand; 1989 Aug; 80(2):130-5. PubMed ID: 2816275
[TBL] [Abstract][Full Text] [Related]
38. Viral antibodies in twins with multiple sclerosis.
Woyciechowska JL; Dambrozia J; Leinikki P; Shekarchi C; Wallen W; Sever J; McFarland H; McFarlin D
Neurology; 1985 Aug; 35(8):1176-80. PubMed ID: 4040615
[TBL] [Abstract][Full Text] [Related]
39. Increased CSF sulfatide levels and serum glycosphingolipid antibody levels in healthy siblings of multiple sclerosis patients.
Haghighi S; Lekman A; Nilsson S; Blomqvist M; Andersen O
J Neurol Sci; 2013 Mar; 326(1-2):35-9. PubMed ID: 23385003
[TBL] [Abstract][Full Text] [Related]
40. Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels.
Calabrese V; Scapagnini G; Ravagna A; Bella R; Foresti R; Bates TE; Giuffrida Stella AM; Pennisi G
J Neurosci Res; 2002 Nov; 70(4):580-7. PubMed ID: 12404512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
